Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Pozycja w akcjach #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Cena akcji
$59.98
Ostatnia synchronizacja: 2024-12-13
Kapitalizacja rynkowa
$1.22B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Longboard Pharmaceuticals, Inc. (LBPH)

Kategoria

Historia ceny akcji dla Longboard Pharmaceuticals, Inc. (LBPH)
Najwyższa cena zamknięcia: $59.98 dnia 2024-12-01

Najniższa cena zamknięcia: $16.35 dnia 2021-03-01
Historia cen akcji firmy Longboard Pharmaceuticals, Inc. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 1,066.59%
2023 27.45%
2022 -27.54%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH